全膝关节置换术中皮质类固醇增强多模式鸡尾酒关节周围注射不增加假体周围关节感染风险
该回顾性队列研究纳入2000至2018年间20382例初次全膝关节置换术患者,比较含醋酸曲安奈德的多模式鸡尾酒关节周围注射(MCPI-S)与不含皮质类固醇的MCPI对术后两年假体周围关节感染(PJI)发生率的影响。结果显示MCPI组PJI发生率为0.5%(51例),MCPI-S组为0.4%(38例),两组差异无统计学意义(P=0.14)。结论认为在MCPI中添加皮质类固醇不增加PJI风险。
要点
- MCPI-S组PJI发生率为0.4%(38例),MCPI组为0.5%(51例),两组差异无统计学意义(P=0.14)。
- 两组处理PJI所需手术干预类型相似(P=0.43)。
- 在MCPI中添加醋酸曲安奈德不增加全膝关节置换术后PJI风险。
核心结论
- 在全膝关节置换术的多模式鸡尾酒关节周围注射中添加皮质类固醇( specifically 醋酸曲安奈德)不增加假体周围关节感染的风险。
研究设计与样本
- 回顾性队列研究,使用纵向维护的机构数据库,纳入2000年至2018年间20382例初次全膝关节置换术患者。
- 患者分为两组:接受含醋酸曲安奈德的MCPI-S组10288例,接受不含皮质类固醇的MCPI组10094例。
- 主要结局为术后两年内假体周围关节感染的发生率,统计比较采用Mann-Whitney U检验和Pearson卡方检验,显著性水平设定为P<0.05。
主要发现
- 总体PJI发生率为0.4%(89例)。
- MCPI组PJI发生率为0.5%(51例),MCPI-S组为0.4%(38例),两组比较P=0.14。
- 两组处理PJI所需手术干预类型相似(P=0.43)。
- 除中位年龄差异0.4年外,两组人口学变量无显著差异,该年龄差异无临床相关性。
临床怎么用
- 作者认为这些发现提供了强有力的证据支持MCPI-S作为多模式疼痛管理策略一部分的安全性和有效性,为其在临床实践中常规使用以促进术后恢复提供了 reassurance。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The addition of corticosteroids to multimodal cocktail periarticular injections (MCPI) during total knee arthroplasty (TKA) has raised concerns about the risks of periprosthetic joint infection (PJI) despite their proven benefits. This study aimed to evaluate the impact of corticosteroid-enhanced multimodal cocktail periarticular injections (MCPI-S) on the incidence of PJI in patients undergoing TKA. METHODS: A retrospective cohort study was conducted using a longitudinally maintained institutional database, including 20,382 patients who underwent primary TKA between 2000 and 2018. Patients were divided into two groups: those receiving MCPI-S containing triamcinolone acetate and those receiving MCPI without corticosteroids. There were 10,094 patients who received MCPI, while 10,288 received MCPI-S during TKA. The primary outcome was the incidence of PJI within two years postoperatively. Statistical comparisons were performed using Mann-Whitney U and Pearson's Chi-square tests, with significance set at P < 0.05. RESULTS: The overall incidence of PJI was 0.4% (89 cases). The MCPI group had a PJI rate of 0.5% (51 cases) compared to 0.4% (38 cases) in the MCPI-S group (P = 0.14). The types of surgical interventions that required to manage PJI were similar between the groups (P = 0.43). There were no significant differences observed in demographic variables, except for a median age difference of 0.4 years, which was not clinically relevant. CONCLUSIONS: The addition of corticosteroids, specifically triamcinolone acetate, to MCPI during TKA does not increase the risk of PJI. These findings provide strong evidence supporting the safety and efficacy of MCPI-S as part of a multimodal pain management strategy, offering reassurance for its routine use in clinical practice to enhance postoperative recovery. LEVEL OF EVIDENCE: III.
引用
- Wong KC, Tay AYW, Liow MHL, et al. Corticosteroid-Enhanced Multimodal Cocktail Periarticular Injection in Total Knee Arthroplasty Does Not Increase Risks of Periprosthetic Joint Infection. J Arthroplasty. 2025. PMID: 40803559. doi:10.1016/j.arth.2025.08.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。